CompletedPhase 3

Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis

Turkey (Türkiye)60 participantsStarted 2020-03-01

Plain-language summary

To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis

Age range40 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Participants who were diagnosed with chronic plantar fasciitis
✓. Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks
✓. Patient should be able to understand the informed consent about type of treatment and blindness and randomization
✓. Visual analog scale pain higher than 5 (on a 10-point visual analog scale)

✕. previous history of any type of local injection treatment for heel pain
✕. history of surgery for heel pain, foot and ankle disorders, fractures
✕. Associated pathology involving the lower limb such as
✕. Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout
✕. Pregnancy
✕. Use of antiocoagulation -

Changes in Visual Analogue Scale (VAS)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

Changes in Foot and Ankle Disability Index (FADI)

Timeframe: 0,1 st 3rd and 6th month; changes between time points will be assessed

NCT IDNCT05240872

SponsorIstanbul Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2020-10-30